| abstract |
To produce a multivalent norovirus vaccine targeting a wide range of norovirus strains. A multivalent norovirus dry powder vaccine composition comprising a first norovirus virus-like particle (VLP) antigen of GI genotype, a second norovirus VLP antigen of GII genotype, and an anionic polysaccharide, immunity against norovirus infection And a method for producing a multivalent dry powder norovirus vaccine composition suitable for both parenteral and mucosal administration. [Selection] Figure 14D |